Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Tenon Medical Inc (TNON)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/16/2025: TNON (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
2 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $2.75
1 Year Target Price $2.75
| 1 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 0% | Avg. Invested days 0 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/16/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 7.42M USD | Price to earnings Ratio - | 1Y Target Price 2.75 |
Price to earnings Ratio - | 1Y Target Price 2.75 | ||
Volume (30-day avg) 2 | Beta 1.23 | 52 Weeks Range 0.85 - 9.35 | Updated Date 07/1/2025 |
52 Weeks Range 0.85 - 9.35 | Updated Date 07/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -2.25 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -506.47% |
Management Effectiveness
Return on Assets (TTM) -81.35% | Return on Equity (TTM) -210.97% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 1219436 | Price to Sales(TTM) 2.26 |
Enterprise Value 1219436 | Price to Sales(TTM) 2.26 | ||
Enterprise Value to Revenue 0.37 | Enterprise Value to EBITDA -0.13 | Shares Outstanding 7589970 | Shares Floating 7568339 |
Shares Outstanding 7589970 | Shares Floating 7568339 | ||
Percent Insiders 0.29 | Percent Institutions 2.01 |
Analyst Ratings
Rating 1 | Target Price 2.75 | Buy 1 | Strong Buy 1 |
Buy 1 | Strong Buy 1 | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Tenon Medical Inc
Company Overview
History and Background
Tenon Medical Inc. is a medical device company focused on developing and commercializing innovative solutions for back pain sufferers. Founded to address limitations in traditional spinal fusion procedures.
Core Business Areas
- Spinal Fixation Systems: Development, manufacturing, and commercialization of the CATANIAu2122 SI Joint Fixation System, a minimally invasive surgical system for sacroiliac joint fusion.
Leadership and Structure
The leadership team is composed of experienced professionals in medical device development, sales, and marketing. The organizational structure includes departments for research and development, manufacturing, sales, marketing, and regulatory affairs.
Top Products and Market Share
Key Offerings
- CATANIAu2122 SI Joint Fixation System: A minimally invasive surgical system for sacroiliac joint fusion. Market share is currently small as the company is still growing. Competitors include SI-BONE (SIBN) and Medtronic (MDT).
Market Dynamics
Industry Overview
The spinal implant and surgical device market is large and growing, driven by an aging population and increasing prevalence of back pain. Innovation in minimally invasive techniques is a key trend.
Positioning
Tenon Medical Inc. is positioned as a provider of minimally invasive SI joint fusion solutions, targeting a specific segment within the broader spinal implant market.
Total Addressable Market (TAM)
The total addressable market for SI joint fusion is estimated to be in the hundreds of millions of dollars annually. Tenon Medical Inc. is positioned to capture a portion of this market with its CATANIA system.
Upturn SWOT Analysis
Strengths
- Proprietary minimally invasive technology
- Focus on a specific market segment (SI joint fusion)
- Potential for faster recovery times compared to traditional fusion
Weaknesses
- Limited market share
- Reliance on a single product
- Small company with limited resources
Opportunities
- Expansion into new geographic markets
- Development of new products for spinal disorders
- Partnerships with larger medical device companies
Threats
- Competition from established players in the spinal implant market
- Changes in reimbursement policies
- Technological advancements that could render their product obsolete
Competitors and Market Share
Key Competitors
- SIBN
- MDT
Competitive Landscape
Tenon Medical Inc. is a smaller player in a market dominated by larger companies. Their competitive advantage lies in their proprietary technology and focus on minimally invasive SI joint fusion.
Growth Trajectory and Initiatives
Historical Growth: Historical growth is limited as the company has just began with their commercialization phase.
Future Projections: Future growth is dependent on the successful commercialization of the CATANIA system and potential expansion into new markets.
Recent Initiatives: Focus on sales and marketing efforts to increase adoption of the CATANIA system.
Summary
Tenon Medical Inc. is a small company with a focused product offering in the spinal implant market. While they have a proprietary technology, they face significant competition from larger, more established players. Successful commercialization of the CATANIA system is critical for their future growth. The company needs to carefully manage its resources and adapt to changes in the market.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company website
- SEC filings
- Industry reports
- Analyst reports
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share estimates are approximate and may vary. Financial data is limited based on public availabliity.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Tenon Medical Inc
Exchange NASDAQ | Headquaters Los Gatos, CA, United States | ||
IPO Launch date 2022-04-27 | CEO, President & Director Mr. Steven M. Foster | ||
Sector Healthcare | Industry Medical Devices | Full time employees 27 | Website https://www.tenonmed.com |
Full time employees 27 | Website https://www.tenonmed.com | ||
Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.